Successful treatment with thalidomide for pemphigus vulgaris

• Váldodahkkit: Bingjie Zhang (Dahkki), Xuming Mao (Dahkki), Wenling Zhao (Dahkki), Hongzhong Jin (Dahkki), Li Li (Dahkki)
• Materiálatiipa: Girji
• Almmustuhtton: SAGE Publishing, 2020-05-01T00:00:00Z.
• Fáttát: article
• Liŋkkat: Connect to this object online.

Background: Pemphigus vulgaris (PV) is a potentially life-threatening mucocutaneous autoimmune blistering disease characterized by suprabasal acantholysis, causing painful mucocutaneous blisters and erosions. Current mainstay therapy for pemphigus is systemic corticosteroids in combination with or w...